Fluticasone/salm Disk 250/50mcg 60s

Manufacturer PRASCO LABORATORIES Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Corticosteroid/Long-Acting Beta2-Adrenergic Agonist Combination
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Aug 2000
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medicine is a combination inhaler used to help people with asthma or COPD breathe better. It contains two main ingredients: a steroid (fluticasone) that reduces swelling and inflammation in your lungs, and a long-acting bronchodilator (salmeterol) that helps open up your airways for up to 12 hours. It's used regularly, twice a day, to prevent breathing problems, not for sudden attacks.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Using Your Inhaler

Use your inhaler at the same time every day, as directed by your doctor or healthcare provider, even if you feel well.
Rinse your mouth with water after each use, but do not swallow the water. Instead, spit it out.
If you are using multiple inhaled medications, ask your doctor which one to use first.

Preparing and Taking a Dose

Only prepare a dose when you are ready to take it. If you prepare a dose and close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged.
Do not breathe out into the inhaler.
After taking your dose, close the inhaler.
Do not take an extra dose, even if you did not taste or feel the powder.

Caring for Your Inhaler

Do not take the device apart or wash it.
Do not use the inhaler with a spacer.
Do not breathe out into the device.
Clean the mouthpiece by wiping it with a dry tissue or cloth. Do not wash it or put it in water.

Tracking Your Doses

The inhaler has a dose counter to help you keep track of how many doses are left.
Throw away the inhaler when the dose counter reaches "0," or 1 month after opening the foil pouch, or after the expiration date, whichever comes first.

Storage and Disposal

Store the medication at room temperature in a dry place, away from the bathroom.
Keep the inhaler in its foil pouch until you are ready to use it.

Missing a Dose

If you miss a dose, skip it and go back to your normal schedule.
* Do not take two doses at the same time or take extra doses.
πŸ’‘

Lifestyle & Tips

  • Use exactly as prescribed, usually one inhalation twice daily, about 12 hours apart. Do not use more often or at higher doses.
  • This is a maintenance medication; it is NOT for sudden breathing problems. Always carry a separate rescue inhaler (e.g., albuterol) for acute symptoms.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth) and hoarseness.
  • Do not stop using this medication suddenly, even if you feel better, without consulting your doctor. Stopping abruptly can worsen your condition.
  • Keep track of your symptoms and how often you use your rescue inhaler. Report any worsening symptoms or increased rescue inhaler use to your doctor.
  • Clean the mouthpiece of the inhaler regularly as instructed by the manufacturer.
  • Do not exhale into the device. Load the dose, exhale fully away from the device, then inhale quickly and deeply through the mouthpiece.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: One inhalation of Fluticasone 250 mcg/Salmeterol 50 mcg twice daily (morning and evening), approximately 12 hours apart.

Condition-Specific Dosing:

asthma: One inhalation of Fluticasone 250 mcg/Salmeterol 50 mcg twice daily.
copd: One inhalation of Fluticasone 250 mcg/Salmeterol 50 mcg twice daily.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for this strength (lower strengths available for children 4-11 years for asthma).
Adolescent: For asthma in adolescents 12 years and older: One inhalation of Fluticasone 100 mcg/Salmeterol 50 mcg or 250 mcg/Salmeterol 50 mcg twice daily, depending on disease severity.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: No dosage adjustment necessary.
Dialysis: No specific recommendations; use with caution due to potential for systemic effects.

Hepatic Impairment:

Mild: No dosage adjustment necessary.
Moderate: Use with caution; monitor for increased systemic corticosteroid effects.
Severe: Use with caution; monitor for increased systemic corticosteroid effects. Fluticasone is primarily metabolized by the liver.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It binds to glucocorticoid receptors, inhibiting the release of inflammatory mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) and suppressing the migration of inflammatory cells (e.g., eosinophils, mast cells, lymphocytes). This reduces airway hyperresponsiveness and inflammation. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It selectively stimulates beta2-adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation by increasing intracellular cyclic AMP (cAMP) levels, which relaxes smooth muscle. The long lipophilic side chain of salmeterol allows it to bind to the exosite of the beta2-receptor, providing a prolonged duration of action (up to 12 hours).
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (<1-2% for inhaled dose); Salmeterol: Low systemic bioavailability (approximately 5-10% for inhaled dose).
Tmax: Fluticasone: 0.5-1 hour (for swallowed portion); Salmeterol: 5-10 minutes (for bronchodilation effect), plasma Tmax not well-defined due to low systemic levels.
FoodEffect: Not applicable for inhaled powder.

Distribution:

Vd: Fluticasone: Approximately 318 L; Salmeterol: Approximately 156 L.
ProteinBinding: Fluticasone: Approximately 91%; Salmeterol: Approximately 96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: Approximately 7.8 hours (terminal); Salmeterol: Approximately 5.5 hours (terminal).
Clearance: Fluticasone: High systemic clearance (approximately 1150 mL/min); Salmeterol: High systemic clearance (approximately 1200 mL/min).
ExcretionRoute: Fluticasone: Primarily feces (unchanged and metabolites); Salmeterol: Primarily feces (approximately 60%) and urine (approximately 25%) as metabolites.
Unchanged: Fluticasone: <5% in urine; Salmeterol: <1% in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (bronchodilation); Fluticasone: Several days to weeks for full anti-inflammatory effect.
PeakEffect: Salmeterol: 2-4 hours; Fluticasone: 1-2 weeks for maximal therapeutic benefit.
DurationOfAction: Salmeterol: 12 hours; Fluticasone: Dose-dependent, but effects persist for 12-24 hours.

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and effectiveness of Fluticasone/Salmeterol in patients with asthma have been established based upon the demonstration of efficacy in clinical trials and the risk of asthma-related death with LABAs. Fluticasone/Salmeterol is not indicated for the relief of acute bronchospasm. Fluticasone/Salmeterol should not be initiated in patients during rapidly deteriorating or life-threatening episodes of asthma or COPD. Fluticasone/Salmeterol should not be used more often than recommended, at higher doses than recommended, or with other LABA-containing products.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Respiratory Emergency

This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek immediate medical attention.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that concern you or persist, contact your doctor:

Headache
Nausea or vomiting
Throat irritation
* Common cold symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough, chest tightness)
  • Increased need for your rescue inhaler (e.g., using it more than 2 days a week, or more than 4 puffs in a day)
  • Sudden, severe difficulty breathing or wheezing immediately after using the inhaler (paradoxical bronchospasm)
  • Signs of infection in the mouth or throat (white patches, soreness, hoarseness)
  • Signs of a serious allergic reaction (rash, hives, swelling of face/lips/tongue, severe dizziness, trouble breathing)
  • Signs of systemic steroid effects (e.g., unexplained weight gain, swelling in ankles/feet, muscle weakness, easy bruising, mood changes, vision changes)
  • Heart palpitations, fast or irregular heartbeat, chest pain
  • Muscle cramps or weakness (signs of low potassium)
  • Increased thirst or urination (signs of high blood sugar)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any medications you are taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.
* This is not an exhaustive list of all potential drug interactions or health problems that may affect the use of this medication.

To ensure your safety, it is crucial to discuss all of your medications (prescription and OTC), natural products, vitamins, and health problems with your doctor and pharmacist. This will help determine whether it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring
It may take approximately 1 week to experience the full effects of this medication. If you have diabetes (high blood sugar), consult your doctor, as this drug may increase your blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Dosage and Administration
Do not exceed the recommended dose or use this medication more often than prescribed. Overdosing on this type of medication has been fatal. Consult your doctor if you have any concerns.

Steroid Replacement Therapy
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these signs. In cases of injury, surgery, or infection, you may require additional oral steroid doses to help your body cope with stress. Carry a warning card indicating that you may need extra steroids in certain situations.

Long-term Use and Potential Risks
Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult your doctor and undergo regular eye exams as recommended. Long-term use may also lead to osteoporosis (weak bones). Discuss your risk factors with your doctor and undergo bone density tests as advised.

Infection Risk and Prevention
You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoid close contact with individuals who have infections, colds, or flu. If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult your doctor.

Special Considerations
If you are 65 or older, use this medication with caution, as you may be more prone to side effects. In children and adolescents, this medication may affect growth in some cases, and regular growth checks may be necessary. Consult your doctor to discuss any concerns.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to weigh the benefits and risks of using this medication.

COPD Considerations
If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk. Discuss this with your doctor to determine the best course of treatment.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia (fast heart rate), palpitations, tremor, headache, nausea, dizziness, hypokalemia, hyperglycemia, chest pain, arrhythmias.
  • Fluticasone overdose (acute): Generally low risk due to low systemic absorption. Chronic overdose may lead to signs of hypercorticism (Cushing's syndrome) and adrenal suppression.

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. Monitor cardiac function (ECG), potassium levels, and blood glucose. Consider a cardioselective beta-blocker for severe salmeterol effects, but use with extreme caution due to risk of bronchospasm.

Drug Interactions

🚫

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin) due to increased systemic exposure to fluticasone and salmeterol, leading to increased risk of Cushing's syndrome, adrenal suppression, and cardiovascular effects (e.g., QTc prolongation, palpitations).
  • Other long-acting beta2-adrenergic agonists (LABAs) due to increased risk of cardiovascular adverse effects.
πŸ”΄

Major Interactions

  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm in asthma patients. Use cardioselective beta-blockers with extreme caution, if at all.
  • Diuretics (loop or thiazide): May potentiate hypokalemia and/or ECG changes associated with beta-agonists, especially at high doses.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension). Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
  • QTc-prolonging drugs (e.g., Class IA and III antiarrhythmics, macrolides, some antipsychotics): Increased risk of ventricular arrhythmias with salmeterol.
🟑

Moderate Interactions

  • Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, grapefruit juice): May increase systemic exposure to fluticasone and salmeterol, requiring caution and monitoring for adverse effects.
  • Xanthine derivatives (e.g., theophylline): May potentiate the hypokalemic effect of salmeterol.
  • Non-potassium-sparing diuretics: May potentiate ECG changes and/or hypokalemia associated with beta-agonists.
🟒

Minor Interactions

  • Not specifically identified as minor, but general caution with other sympathomimetics due to additive effects.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Asthma/COPD Control Assessment (e.g., ACT, CAT scores)

Rationale: To establish baseline symptom control and quality of life.

Timing: Prior to initiation of therapy.

Electrolytes (Potassium)

Rationale: Salmeterol can cause transient hypokalemia, especially in susceptible patients or with concomitant diuretics.

Timing: Consider for patients at risk of hypokalemia.

ECG

Rationale: Salmeterol can cause cardiovascular effects (e.g., QTc prolongation).

Timing: Consider for patients with pre-existing cardiovascular disease or risk factors.

πŸ“Š

Routine Monitoring

Pulmonary Function Tests (e.g., FEV1)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Improvement from baseline or maintenance of optimal function.

Action Threshold: Worsening FEV1 or lack of improvement may indicate inadequate control or need for re-evaluation.

Asthma/COPD Symptom Control

Frequency: Regularly (e.g., at each follow-up visit)

Target: Minimal symptoms, no nocturnal awakenings, minimal rescue inhaler use.

Action Threshold: Increased symptoms, increased rescue inhaler use, or exacerbations indicate need for treatment adjustment.

Growth (in pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age.

Action Threshold: Growth retardation may indicate systemic corticosteroid effects; consider lowest effective dose.

Signs/Symptoms of Adrenal Suppression or Cushing's Syndrome

Frequency: Periodically, especially with high doses or long-term use

Target: Absence of symptoms (e.g., fatigue, weight gain, moon face, easy bruising).

Action Threshold: Presence of symptoms warrants evaluation and potential dose reduction or withdrawal.

Ocular Examination (for cataracts/glaucoma)

Frequency: Annually for long-term users, especially those with risk factors

Target: Normal intraocular pressure, absence of cataracts.

Action Threshold: Increased IOP or cataract formation may require ophthalmologic referral.

Bone Mineral Density (BMD)

Frequency: Consider baseline and periodically for patients at risk of osteoporosis (e.g., long-term high-dose ICS use)

Target: Stable BMD.

Action Threshold: Significant bone loss may require intervention (e.g., calcium/vitamin D, bisphosphonates).

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma/COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for rescue inhaler (SABA)
  • Paradoxical bronchospasm (immediate worsening of breathing after inhalation)
  • Signs of systemic corticosteroid effects (e.g., oral candidiasis, hoarseness, easy bruising, weight gain, mood changes, fatigue)
  • Cardiovascular symptoms (e.g., palpitations, chest pain, increased heart rate)
  • Hypokalemia symptoms (e.g., muscle weakness, cramps, arrhythmias)
  • Hyperglycemia symptoms (e.g., increased thirst, urination)
  • Signs of infection (e.g., fever, increased cough, sputum changes)

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown teratogenic effects with high doses of fluticasone and salmeterol.

Trimester-Specific Risks:

First Trimester: Potential for teratogenic effects observed in animal studies at high doses. Clinical data are limited.
Second Trimester: Continued monitoring of maternal asthma control is crucial. Uncontrolled asthma poses greater risks to both mother and fetus than medication.
Third Trimester: Monitor for signs of fetal adrenal suppression if high doses of fluticasone are used. Salmeterol may inhibit labor due to its beta-agonist effects.
🀱

Lactation

L3 (Moderately Safe). It is not known whether fluticasone or salmeterol are excreted in human milk. Other corticosteroids are excreted in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Fluticasone/Salmeterol and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition. Use with caution.

Infant Risk: Low to moderate risk. Monitor breastfed infants for signs of systemic corticosteroid effects (e.g., growth suppression) or beta-agonist effects (e.g., irritability, tremor, tachycardia), though systemic exposure is expected to be low.
πŸ‘Ά

Pediatric Use

Not indicated for children under 4 years of age. For children 4-11 years with asthma, lower strengths (e.g., 100/50 mcg or 50/50 mcg) are available. Monitor growth velocity closely in pediatric patients receiving inhaled corticosteroids, as they may cause a reduction in growth velocity. Monitor for signs of adrenal suppression.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals to the effects of the drug cannot be ruled out. Use with caution in elderly patients with co-morbidities such as cardiovascular disease, diabetes, or glaucoma, as they may be more susceptible to the systemic effects of beta-agonists and corticosteroids.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fluticasone/salmeterol is a maintenance therapy and should not be used for acute bronchospasm. Patients should always have a rescue inhaler (e.g., albuterol) available.
  • Proper inhaler technique is crucial for efficacy. Educate patients on how to use the Diskus device correctly, including loading the dose, exhaling fully away from the device, inhaling quickly and deeply, and holding their breath.
  • Rinsing the mouth and spitting out water after each dose is essential to minimize the risk of oral candidiasis (thrush) and dysphonia (hoarseness).
  • Patients should be advised not to stop the medication abruptly, as this can lead to worsening asthma or COPD symptoms and potential adrenal insufficiency if on high doses for prolonged periods.
  • Regular follow-up is important to assess symptom control, lung function, and monitor for potential adverse effects, especially systemic corticosteroid effects and cardiovascular effects.
  • The black box warning regarding increased risk of asthma-related death with LABAs should be discussed with patients, emphasizing that the combination with an ICS mitigates this risk, but the drug should not be used for acute symptoms or in rapidly deteriorating asthma.
πŸ”„

Alternative Therapies

  • Inhaled corticosteroids (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone) for asthma not controlled by SABA alone.
  • Long-acting beta2-adrenergic agonists (LABA) monotherapy (e.g., salmeterol, formoterol, arformoterol, indacaterol, olodaterol) for COPD (not recommended for asthma monotherapy due to black box warning).
  • Long-acting muscarinic antagonists (LAMA) monotherapy (e.g., tiotropium, umeclidinium, glycopyrronium) for COPD.
  • Triple therapy (ICS/LABA/LAMA) for severe COPD (e.g., Trelegy Ellipta, Breztri Aerosphere).
  • Leukotriene receptor antagonists (e.g., montelukast) for asthma.
  • Oral corticosteroids for severe exacerbations or refractory disease.
πŸ’°

Cost & Coverage

Average Cost: $300 - $500 per 60-dose inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (preferred brand or non-preferred brand, generic often Tier 1)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.